Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Gudkov

Showing results (1-10 of 476) with videos related to

Pageof 48
Sort By:
Ultrasonics|June 30, 2006
Doppler-shifted cyclotron, doppleron-phonon, and pseudo-doppleron-phonon resonances in indiumV V Gudkov
Nature Medicine|December 8, 2004
Cancer drug discovery: the wisdom of imprecisionAndrei V Gudkov
Bulletin of Experimental Biology and Medicine|December 23, 2009
Experience of long-term afala treatment in benign prostatic hyperplasiaA V Gudkov
Nature Medicine|November 2, 2002
Converting p53 from a killer into a healerAndrei V Gudkov
Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia|August 1, 1987
[Multiple drug resistance of tumor cells: manifestations, genetic basis, clinical aspects]A V Gudkov
International Journal of Radiation Oncology, Biology, Physics|February 12, 2008
In regard to Schuller et Al. (Int J Radiat Oncol Biol Phys 2007;68:205-210)Andrei V Gudkov, Anatoly Gleiberman
Nature Reviews. Cancer|February 4, 2003
The role of p53 in determining sensitivity to radiotherapyAndrei V Gudkov, Elena A Komarova
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2003
Genetic suppressor elements in the characterization and identification of tumor suppressor genesIgor B Roninson, Andrei V Gudkov
Somatic Cell and Molecular Genetics|July 10, 2001
Generation of p53 suppressor peptide from the fragment of p53 proteinJ M Mittelman, A V Gudkov
Seminars in Cancer Biology|April 2, 1999
Could p53 be a target for therapeutic suppression?E A Komarova, A V Gudkov
Pageof 48

Showing results (1-10 of 476) with videos related to

Sort By:
Pageof 48
Ultrasonics|June 30, 2006
Doppler-shifted cyclotron, doppleron-phonon, and pseudo-doppleron-phonon resonances in indiumV V Gudkov
Nature Medicine|December 8, 2004
Cancer drug discovery: the wisdom of imprecisionAndrei V Gudkov
Bulletin of Experimental Biology and Medicine|December 23, 2009
Experience of long-term afala treatment in benign prostatic hyperplasiaA V Gudkov
Nature Medicine|November 2, 2002
Converting p53 from a killer into a healerAndrei V Gudkov
Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia|August 1, 1987
[Multiple drug resistance of tumor cells: manifestations, genetic basis, clinical aspects]A V Gudkov
International Journal of Radiation Oncology, Biology, Physics|February 12, 2008
In regard to Schuller et Al. (Int J Radiat Oncol Biol Phys 2007;68:205-210)Andrei V Gudkov, Anatoly Gleiberman
Nature Reviews. Cancer|February 4, 2003
The role of p53 in determining sensitivity to radiotherapyAndrei V Gudkov, Elena A Komarova
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2003
Genetic suppressor elements in the characterization and identification of tumor suppressor genesIgor B Roninson, Andrei V Gudkov
Somatic Cell and Molecular Genetics|July 10, 2001
Generation of p53 suppressor peptide from the fragment of p53 proteinJ M Mittelman, A V Gudkov
Seminars in Cancer Biology|April 2, 1999
Could p53 be a target for therapeutic suppression?E A Komarova, A V Gudkov
Pageof 48